NCT04894461

Efficacy of Moxibustion in Diabetes Peripheral Neuropathy

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Xiamen University · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This pragmatic randomized controlled study aimed to evaluate the effectiveness and safety of moxibustion therapy on diabetes peripheral neuropathy.

Detailed description

Background: The purpose of this study is to investigate the clinical effects of moxibustion for treating diabetes peripheral neuropathy. Hypothesis: Subjects who have participated in the moxibustion treatment will have greater improvement in people with diabetes with signs and symptoms of peripheral neuropathy than the control group after 8 weeks. Design and subjects: A pilot randomized controlled trial. Subjects with diabetes peripheral neuropathy will be recruited from the community. 30 subjects will be randomized to moxibustion groups and control groups in a 1:1 ratio. Interventions: Subjects in the moxibustion group will receive three times per week for 12 weeks; control groups will be allocated to the waitlist will receive no moxibustion treatments throughout the 8 weeks.

Conditions

• Peripheral Neuropathy
• Diabetic Neuropathies

Interventions

Type	Name	Description
DEVICE	Moxibustion	The moxibustion treatment sessions are three times per week for eight weeks. Indirect moxa stick will be used.

Timeline

• Start date: 2021-11-01
• Primary completion: 2023-09-30
• Completion: 2023-12-30
• First posted: 2021-05-20
• Last updated: 2021-05-20